Literature DB >> 15858300

Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study.

S Naik1, A H Hegde.   

Abstract

The retention of pulpally involved deciduous tooth in a healthy state until the time of normal exfoliation remains to be one of the challenges for Pedodontists. A scientific noise has been generated about several materials some of which have been popular pulpotomy medicaments. Concerns have been raised about the toxicity and potential carcinogenicity of these materials, and alternatives have been proposed to maintain the partial pulp vitality, however to date no material has been accepted as an ideal pulpotomy agent. Mineral trioxide aggregate (MTA) is a biocompatible material which provides a biological seal. MTA has been proposed as a potential medicament for various pulpal procedures like pulp capping with reversible pulpitis, apexification, repair of root perforations, etc. Hence the present study was done to evaluate the efficacy of MTA as a pulpotomy medicament. A clinical and radiographic evaluation was done on children where MTA was used as pulpotomy medicament in primary molars for a period of 6 months and it was found to be a successful material.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858300     DOI: 10.4103/0970-4388.16020

Source DB:  PubMed          Journal:  J Indian Soc Pedod Prev Dent        ISSN: 0970-4388


  28 in total

1.  Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars.

Authors:  Cameron M Zealand; Daniel M Briskie; Tatiana M Botero; James R Boynton; Jan C C Hu
Journal:  Pediatr Dent       Date:  2010 Sep-Oct       Impact factor: 1.874

Review 2.  Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol.

Authors:  E Stringhini Junior; M E B Vitcel; L B Oliveira
Journal:  Eur Arch Paediatr Dent       Date:  2015-04-02

Review 3.  Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Armin Shirvani; Saeed Asgary
Journal:  Clin Oral Investig       Date:  2014-01-23       Impact factor: 3.573

4.  Color stability of white mineral trioxide aggregate.

Authors:  Marta Vallés; Montserrat Mercadé; Fernando Duran-Sindreu; Jose Luis Bourdelande; Miguel Roig
Journal:  Clin Oral Investig       Date:  2012-07-20       Impact factor: 3.573

5.  Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.

Authors:  John M Sushynski; Cameron M Zealand; Tatiana M Botero; James R Boynton; Robert F Majewski; Charles E Shelburne; Jan Chingchun Hu
Journal:  Pediatr Dent       Date:  2012 Sep-Oct       Impact factor: 1.874

Review 6.  Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-06

7.  Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis.

Authors:  Sarah E Mettlach; Cameron M Zealand; Tatiana M Botero; James R Boynton; Robert F Majewski; Jan ChingChun Hu
Journal:  Pediatr Dent       Date:  2013 May-Jun       Impact factor: 1.874

Review 8.  Mineral trioxide aggregate as a pulpotomy medicament: a narrative review.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-03

Review 9.  Pulpotomy in primary teeth: review of the literature according to standardized criteria.

Authors:  A B Fuks; L Papagiannoulis
Journal:  Eur Arch Paediatr Dent       Date:  2006-06

10.  Knowledge and Practice of Pulp Therapy in Deciduous Teeth among General Dental Practitioners in Saudi Arabia.

Authors:  Ra Togoo; Vs Nasim; M Zakirulla; Sm Yaseen
Journal:  Ann Med Health Sci Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.